$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
The protocol detailed above describes the methods employed in Nishimoto et al., 2015. The paper studies limb bud induction and initiation in both the fore and hindlimb of the chick embryo. Results following the insertion of impermeable barriers to prevent the outgrowth of the forelimb bud have been published previously 1, 2, 9 but there has been only one study describing barriers preventing leg bud initiation 1. Hindlimb data from Nishimoto et al., 2015 are presented here as representative results of the study of mRNA expression following barrier insertion.
Tbx4 Expression in the LPM Is Not Sufficient to Initiate Hindlimb Outgrowth:
Figures 2B and C (Table 2) show that barrier insertion at stage 15 (Figure 2A) (see protocol 3.2) leads to both Fgf10 and Fgf8 expression being absent in the leg bud region (denoted by bracket) on the operated right side. Compare with the unoperated left side. However, Tbx4 expression is observed at both stage 19 and stage 23 on the operated side (Figure 2D and E). We conclude that Tbx4 expression alone is not sufficient to initiate hindlimb outgrowth from the LPM. Other studies in the chick have suggested that Tbx gene expression is sufficient to initiate forelimb bud formation 12, 13.
Figure 2C' is included to illustrate how a barrier looks imbedded in the leg region of the embryo post fixation. In the majority of cases barriers were removed prior to in situ hybridization (protocol 4.3).
RA from the Somites Is Essential in the LPM before Fgf10 Induces Limb Bud Outgrowth:
Figure 3A is a schematic representing the addition of an RA soaked bead distal to a barrier inserted at stage 15 (protocol 3.2.1.3). Subsequent to this operation limb bud outgrowth (denoted by an asterisk) is observed on the operated right side and Tbx4, Fgf10 and Fgf8 are expressed in the bud as they are in the control left side (Figure 3B, C and D, Table 2). Thus addition of RA to the LPM overcomes the effect of the barrier and limb bud initiation proceeds. We conclude that in normal development RA from the somites is essential in the LPM before limb bud outgrowth can be initiated. The resulting hindlimb buds are generally smaller than those on the control side. This may be due to the RA dose in the LPM being not equivalent to the wild type situation. If the RA dose is too high the Apical Ectodermal Ridge (AER) can be shortened and smaller buds would result 14, 15.
To confirm that RA (from the somites) in the LPM is required for normal limb bud initiation an inverse agonist of RAR, BMS 493, was used. Beads are implanted into the leg region LPM at stage 15 (see protocol 3.2.1.4) (Figure 3E). Fgf10 expression is downregulated following application of BMS 493 beads in the LPM, resulting in smaller hindlimb buds compared to the control side (Figure 3F; Table 3). Control DMSO beads do not cause these defects (Figures 3G and 3H; Table 3). The defects observed following BMS 493 application are milder than those induced by a barrier operation; i.e., Fgf10 is still expressed and limb buds are formed. This is likely to be because the effects of BMS 493 are restricted locally around the beads and may not be able to antagonize all the RA produced by axial tissues.
Early Axial Signals Specify the LPM Cells that Later Express Tbx4:
We tested when the LPM acquires its ability to express Tbx4 in the prospective leg-forming region. The earliest stage at which a barrier can be inserted that will subsequently block leg bud outgrowth, is stage 10. We are the first to develop a protocol to insert barriers at stages earlier than stage 12. Barriers inserted between the paraxial mesoderm and the presumptive leg LPM at stage 10 (see protocol 3.4) block leg bud formation and the expression of Tbx4 in the leg-forming LPM (Figures 2F and 2G, Table 2), suggesting that a signal from axial tissues at stage 10 is required for later expression of Tbx4 in hindlimb LPM. Compare this result with Figures 2D and E where later barrier insertion allows Tbx4 expression to be established. Furthermore, we tested whether this axial signal could be RA by observing whether the inverse agonist of RAR reduces Tbx4 expression. A BMS 493 bead placed in the hindlimb LPM at stage 10 (see protocol 3.4.1.3) downregulates Tbx4 expression (Figures 2H and 2I), whereas control beads soaked in DMSO do not affect Tbx4 expression (Figures 2J and 2K). Together, these results support a model that an RA signal from axial tissues regulates limb induction by positively regulating Tbx4 in the hindlimb LPM 7.
Post-operative Death:
Tables 1, 2 and 3 give details of experimental outcomes including the number of chick embryos that died post operation and before harvesting. Some deaths are to be expected after microsurgery of this nature. The numbers dying can be kept to a minimum by making sure that instruments are clean, the hole in the egg is the minimum size required, that the embryos are left without the protection of the sticky tape seal for a minimum time and, in conjunction with this last point that the operation is carried out as quickly as possible. None of these operations are very time consuming but operations involving beads and barriers take a little more time. Despite these measures, operations carried out at the earliest stages and those in the wing region are more likely to result in death. There are large blood vessels around the limb-forming regions and accidental rupture of these vessels may lead to death due to blood loss. We find that eggs opened at stage 8 or 9, whose embryos have not been operated on, will often die by the next day. Therefore, the only solution to these problems is to carry out a high number of experiments.

Figure 2. Marker Gene Expression Changes following Barrier or Bead Insertion at Presumptive Leg Level. (A) Schematic showing barrier position (green line) at the presumptive leg level (somites 26-32) in a stage 15 embryo. (B-E and G) WISH analysis on operated embryos. The leg region is outlined (brackets). (B) Fgf10 expression is absent in the operated LPM, but robust expression is detected in the left bud. (C) Fgf8 expression is absent in the operated side, suggesting there is no AER. (C') The same embryo before the barrier was removed. (D) Tbx4 is expressed in the LPM at the same rostro-caudal level as the control bud. (E) Tbx4 expression is maintained in the right leg region despite absence of limb growth. (F) Schematic diagram of a stage 10 chick embryo showing barrier position (green line) at the presumptive leg level. (G) Tbx4 expression is absent in the operated right LPM (bracket). (H) Schematic diagram of a stage 10 chick embryo showing BMS 493 bead position (purple circle) at the presumptive leg level. (I) Tbx4 expression is downregulated on the operated right side following treatment with BMS 493. (J) Schematic diagram of a stage 10 chick embryo showing control DMSO bead position (gray circle). (K) Tbx4 is expressed on the operated right side at a similar level to that of control left side following treatment with DMSO alone. This figure has been modified from 7. Please click here to view a larger version of this figure.

Figure 3. RA Rescues Limb Bud's Absence Caused by Barrier Insertion and is Essential in the LPM Prior to Leg Bud Outgrowth. (A) Schematic diagram indicating barrier position (green line) at the presumptive leg level (somites 26-32) and an RA-soaked bead (red circle). (B-D) RA rescues leg bud outgrowth (shown by an asterisk). (B) Tbx4 expression is present in the rescued leg bud similar to the un-operated side. (C) Fgf10 is expressed in the rescued leg bud similar to the un-operated side. (D) Fgf8 is expressed in the AER of the rescued right leg bud. (E) Schematic indicating where BMS 493 beads (purple circles) were placed in the presumptive leg LPM of stage 15 embryos. (F) Fgf10 expression is downregulated on the operated right side and the leg bud is small following BMS 493 treatment. Beads are asterisked. (G) Similar schematic to (E), indicating the position of control DMSO beads (gray circles). (H) DMSO beads (shown by asterisks) did not affect Fgf10 expression or leg bud size. This figure has been modified from 7. Please click here to view a larger version of this figure.
| Stage barrier placed (+ bead) * | Number operated | Wing missing ** | Wing present ** | Number dead |
| Stage 12-14 | 40 | 24 | 1 | 15 |
| Stage 8/9 | 65 | 23 | 0 | 42 |
| Stage 12-13 (FGF4 bead) | 41 | 7 (bead missing) | 17 | 17 |
| Stage 12-13 (RA bead) | 75 | 9 (bead missing) | 32 | 34 |
| Stage 13 (control bead) | 5 | 3 | 0 | 2 |
| * 0.7-1 mm foil barriers placed between somites 15-20 and the lateral plate mesoderm. 0.35 mg/ml FGF4 bead. 0.05-0.1 mg/ml RA bead. |
| DMSO control bead. |
| ** Chick embryos fixed stages 21-23 |
Table 1. Wing Level Barrier and Bead Experiment Outcomes.
| Stage barrier placed (+ bead) * | Number operated | Leg missing ** | Leg present ** | Number dead |
| Stage 12-15 | 43 | 39 | 0 | 4 |
| Stage 10/11 | 23 | 16 | 0 | 7 |
| Stage 15 (FGF4 bead) | 8 | 0 | 5 | 3 |
| Stage 15 (RA bead) | 18 | 0 | 18 | 0 |
| * 0.7-1.3 mm foil barriers placed between somites 26-32 and the lateral plate mesoderm. 0.35 mg/ml FGF4 bead. 0.05-0.1 mg/ml RA bead. |
| ** Chick embryos fixed stages 18-24 |
Table 2. Leg Level Barrier and Bead Experiment Outcomes.
| Number operated | Leg bud small | Leg bud slightly small | Leg bud normal size | Number dead |
| BMS 493 beads * | | | | |
| 15 | 12 | 3 | 0 | 0 |
| DMSO beads ** | | | | |
| 12 | 0 | 3 | 9 | 0 |
| * 2-3 beads soaked in 5 mg/ml BMS 493 placed in the right stage 14-15 LPM at leg level. |
| ** 2-3 beads soaked in DMSO alone placed in the right stage 15 LPM at leg level. |
| Chick embryos fixed at stages 17-19. |
Table 3. Leg Level BMS 493 Bead Experiment Outcomes.